These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34680244)

  • 1. Clinical Characteristics of Resected Acinar Cell Carcinoma of the Pancreas: A Korean Multi-Institutional Study.
    Shin SH; Hwang HK; Jang JY; Kim H; Park SJ; Han SS; Han IW; Hwang DW; Heo JS
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
    Huang X; Li M; Zhang L; Xiong J; Lu H; Tian B
    Surg Oncol; 2021 Jun; 37():101528. PubMed ID: 33611029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry Group.
    Petrova E; Wellner J; Nording AK; Braun R; Honselmann KC; Bolm L; Hummel R; Klinkhammer-Schalke M; Zeissig SR; Kleihues van Tol K; Timme-Bronsert S; Bronsert P; Zemskov S; Keck T; Wellner UF
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma.
    Sun T; Gilani S; Jain D; Cai G
    Diagn Cytopathol; 2023 Nov; 51(11):674-683. PubMed ID: 37469257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.
    Florou V; Elliott A; Bailey MH; Stone D; Affolter K; Soares HP; Nevala-Plagemann C; Scaife C; Walker P; Korn WM; Lou E; Shroff RT; Hosein PJ; Garrido-Laguna I
    Clin Cancer Res; 2023 Sep; 29(17):3408-3417. PubMed ID: 37266563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of patients with resectable pancreatic acinar cell carcinoma.
    Seo S; Yoo C; Kim KP; Ryoo BY; Chang HM; Hong SM; Lee JH; Song KB; Hwang DW; Kim KH; Hwang S; Kim SC
    J Dig Dis; 2017 Aug; 18(8):480-486. PubMed ID: 28671770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
    McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
    Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
    Skorupan N; Ghabra S; Maldonado JA; Zhang Y; Alewine C
    J Cancer Metastasis Treat; 2023; 9():. PubMed ID: 37538977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection of hepatic and rectal metastases of pancreatic acinar cell carcinoma (PACC): a case report.
    Ohara Y; Oda T; Enomoto T; Hisakura K; Akashi Y; Ogawa K; Owada Y; Domoto Y; Miyazaki Y; Shimomura O; Kurata M; Ohkohchi N
    World J Surg Oncol; 2018 Aug; 16(1):158. PubMed ID: 30075727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathologic characterisitics of pancreatic acinar cell carcinomas].
    Ding XH; Wang ZB; Qiu XM
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):274-278. PubMed ID: 29690667
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
    Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
    Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers.
    La Rosa S; Adsay V; Albarello L; Asioli S; Casnedi S; Franzi F; Marando A; Notohara K; Sessa F; Vanoli A; Zhang L; Capella C
    Am J Surg Pathol; 2012 Dec; 36(12):1782-95. PubMed ID: 23026929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the role of systemic therapy in resectable pancreatic acinar cell carcinoma.
    Burchard PR; Chacon AC; Melucci A; Casabianca AS; Goyal S; Switchenko JM; Maithel SK; Kooby DA; Carpizo DR; Shah MM
    J Surg Oncol; 2022 Apr; 125(5):856-864. PubMed ID: 34994405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Referral and treatment patterns in pancreatic acinar cell carcinoma: A regional population-level analysis.
    Patel RK; Parappilly M; Sutton TL; Behrens S; Schwantes IR; Johnson AJ; Pommier RF; Sheppard BC
    Am J Surg; 2024 May; 231():55-59. PubMed ID: 37087362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymph node metastasis regularity and risk factors in 768 cardiac carcinoma patients].
    Yue J; Duan X; Gong L; Zhang J; Yu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Nov; 20(11):1283-1287. PubMed ID: 29178100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic Ductal Adenocarcinoma in Remnant Pancreas after Pancreaticoduodenectomy for Acinar Cell Carcinoma: A Case Report.
    Nishimura S; Utsumi M; Aoki H; Une Y; Kashima H; Kimura Y; Taniguchi F; Arata T; Katsuda K; Tanakaya K; Sato Y
    J Nippon Med Sch; 2019 Dec; 86(5):279-283. PubMed ID: 31061255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas.
    Swartz MJ; Hsu CC; Pawlik TM; Winter J; Hruban RH; Guler M; Schulick RD; Cameron JL; Laheru DA; Wolfgang CL; Herman JM
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):839-44. PubMed ID: 19647950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of postoperative adjuvant therapy in resected invasive intraductal papillary mucinous neoplasm of the pancreas: A multicenter external validation.
    Choi M; Chong JU; Hwang HK; Seo HI; Yang K; Ryu JH; Roh Y; Kim DH; Lee JH; Lee WJ; Choi SH; Kang CM
    J Hepatobiliary Pancreat Sci; 2021 Aug; 28(8):671-679. PubMed ID: 34028187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.